Search Results 741-750 of 14000 for anti-TNF drugs

  1. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Participation eligibility.

  2. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

    Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...

  3. AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke - Mayo Clinic

    Objectives - Primary: To test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in patients with cryptogenic ischemic ...

  4. A Safety Study of SEA-TGT (SGN-TGT) in Patients With Advanced Cancer - Mayo Clinic

    This trial will look at a drug called SGN-TGT (an anti-TIGIT antibody) to find out whether it is safe for patients with solid tumors and lymphomas. It will ...

  5. A Study Combining Tofacitinib with Gemcitabine for the Treatment of Pancreas Cancer in Patients who are Losing Weight - Mayo Clinic

    The purpose of this study is to test the safety, tolerability and possible benefit of a drug called tofacitinib in patients with metastatic pancreas cancer when ...

  6. Tenofovir (oral route) - Mayo Clinic

    Tenofovir is used in combination with other medicines for the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the virus that ...

  7. CJNJ-67652000 and Prednisone for the Treatment of Men With Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations - Mayo Clinic

    Giving CJNJ-67652000 and prednisone may kill more tumor cells in patients with metastatic prostate cancer than giving these drugs alone. Participation ...

  8. A Study to Optimize Endocrine Therapy Through Motivational Interviewing and Text Interventions - Mayo Clinic

    This study aims to compare an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer ...

  9. Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies - Mayo Clinic

    Previous treatment with any anti-CD38 therapy; Patients with concurrent plasma cell leukemia; Patients with known or suspected amyloidosis; Karnofsky ...

  10. Daratumumab and hyaluronidase-fihj (subcutaneous route) - Mayo Clinic

    ... treatment with this medicine and continue for 3 months after treatment. ... Drugs & Supplements. Daratumumab and hyaluronidase-fihj (subcutaneous route) ...